- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | SRX Global Inc: SRX Global Provides Update on Balance Sheet and Share Buyback | 1 | GlobeNewswire (USA) | ||
| 26.10. | SRX Global Inc: SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics' Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies | 3 | GlobeNewswire (USA) | ||
| 08.10. | SRX Global Inc: SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform | 452 | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| 07.10. | SRX Global Inc: SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies | 181 | GlobeNewswire (Europe) | SPV, CERO 1236, to raise capital directly into subsidiary and not dilute existing SRX Global shareholders Proposed acquisition expected to accelerate development of CERo's lead product candidate,... ► Artikel lesen | |
| SRX GLOBAL Aktie jetzt für 0€ handeln | |||||
| 06.10. | SRX Global Inc: SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim | 7 | GlobeNewswire (USA) | ||
| 06.10. | SRX Global Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 24.09. | SRX Global Inc: SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) | 559 | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| 03.09. | SRX Global Inc: SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company | 317 | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| 02.09. | SRX Global Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.08. | SRX Global Inc: SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers | 490 | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., Aug. 31, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| 19.08. | SRX Global Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 14.08. | SRX Global Inc. GAAP EPS of -$0.36, revenue of $3.4M | 2 | Seeking Alpha | ||
| 13.08. | SRX Global reduziert Verlust im dritten Quartal bei steigendem Umsatz | 5 | Investing.com Deutsch | ||
| 04.08. | SRX Global Inc: SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN) | 380 | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| 03.08. | SRX Global Inc: SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger | 4 | GlobeNewswire (USA) | ||
| 30.07. | SRX Global Inc: SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering | 2 | GlobeNewswire (USA) | ||
| 21.07. | SRX Global Inc. - 8-K, Current Report | 14 | SEC Filings | ||
| 16.07. | SRX Global regains full NYSE American listing compliance | 1 | Seeking Alpha | ||
| 16.07. | SRX Global Inc: SRX Global Regains Full Compliance with NYSE American Listing Standards | 354 | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction... ► Artikel lesen | |
| 14.07. | SRX Global Inc: SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026 | 3 | GlobeNewswire (USA) |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SENSEONICS | 10,000 | +14,29 % | Mizuho hebt Kursziel für Senseonics nach starken Q3-Zahlen an | ||
| INCANNEX HEALTHCARE | 2,190 | 0,00 % | Stonegate, Inc.: Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26 | Dallas, Texas--(Newsfile Corp. - October 1, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). IXHL's FY26... ► Artikel lesen | |
| ITONIC | 1,840 | +1,10 % | iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026 | BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (Nasdaq: ITOC) (the "Company"), a healthcare company developing digital medical technologies, today announced that at the extraordinary... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,370 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| HEARTFLOW | 56,65 | -0,02 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,290 | +0,30 % | Börsenfrühstück: Rheinmetall kappt Ziele, Hensoldt hebt an, Renk, Telekom, Commerzbank, Healthineers, Qualcomm | Die Wall Street hat die US-Zwischenwahlen mit einem kräftigen Kursfeuerwerk quittiert. Nachdem die Demokraten die Mehrheit in beiden Kammern des Kongresses errungen hatten, schloss der Dow Jones gestern... ► Artikel lesen | |
| FRESENIUS | 53,23 | +1,47 % | Ihre wichtigsten Termine: Frische Zahlen von: Uber, Novo Nordisk, Qualcomm, Allstate, McDonald's und BMW | © Foto: Steffen Trumpf/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0200021014... ► Artikel lesen | |
| PROGYNY | 35,960 | 0,00 % | Progyny, Inc. - 10-Q, Quarterly Report | ||
| STARLING ONCOLOGY INSTITUTE | 4,005 | +0,12 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| FRESENIUS MEDICAL CARE | 40,900 | -0,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung gemäß § 50 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Drittstaatveröffentlichung nach § 50 Abs. 1, Nr. 2 WpHG
Fresenius Medical Care AG: Veröffentlichung gemäß §... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,535 | 0,00 % | Privia Health Group, Inc. - 10-Q, Quarterly Report | ||
| GUARDIAN PHARMACY SERVICES | 46,970 | -0,06 % | Guardian Pharmacy forecasts $1.44B-$1.46B 2026 revenue and $136M-$138M adjusted EBITDA as it expands in Texas and Alabama | ||
| ALIGNMENT HEALTHCARE | 7,265 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| GMR SOLUTIONS | 11,270 | 0,00 % | GMR Solutions Inc. - 10-Q, Quarterly Report | ||
| ARDENT HEALTH | 17,980 | 0,00 % | Ardent Health raises 2026 adjusted EBITDA outlook to $500M-$535M as Kansas divestiture targets +40 bps margin lift |
SRX GLOBAL INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,008 (-0,93 %) liegt der Kurs bei 0,875 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SRX GLOBAL INC finden Sie auf Wallstreet Online.